Abbott launches Panbio COVID-19 antigen self-test in India

Abbott launches Panbio COVID-19 antigen self-test in India

Abbott has launched Panbio COVID-19 rapid antigen self-test in India, for the detection of the SARS-CoV-2 virus in adults and children with or without symptoms.

The test which gives results in just 15 minutes contains all the materials required including nasal swabs, test devices and reagent ampules. People can take the test by using a simple nasal swab without requiring a deep nasopharyngeal swab while following the instructions on the pack. These self-test kits are offered in packages of one, four, 10 and 20 tests.

The test is to be used along with Abbott’s NAVICA mobile app, available in the Google Play and Apple app store. The app offers a simple and streamlined process of self-registration, automatic reading of results and easy reporting as per ICMR guidelines.

The company also offers the Panbio COVID-19 Ag rapid test device for professional use. This version of the test – which is scientifically identical to the self-test– can be administered by health professionals on adults and children, with or without symptoms. Like the Panbio self-test, the professional test offers a minimally invasive nasal swab option for the assisted, supervised sample collection, which can help people who are not comfortable with the deep nasopharyngeal swab. It delivers results in 15 minutes.

Panbio professional test demonstrated 95.7% sensitivity and 97.6% specificity when benchmarked against RT-PCR tests, indicating high reliability, according to report on evaluation of Panbio COVID-19 Ag rapid test device (NASAL), SARS CoV-2 antigen test kits, Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), April 2021.

Panbio has CE Mark for asymptomatic use and supervised nasal swab collection and is on the World Health Organization (WHO) Emergency Use Listing. Abbott has shipped 300 million Panbio COVID-19 Antigen Rapid tests for professional use in more than 100 countries across Europe, the Americas, Asia and Africa.

Panbio self-tests will be available via retail pharmacies and through e-commerce platforms, as well as through organizations and institutions.